Travere Therapeutics (TVTX) Free Cash Flow Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 137.65% |
| 10 | Travere Therapeutics | 4.34 Bn | 4.26 Bn | 102.38 Mn | 4.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.33% |
| Dec 31, 2025 | 314.65% |
| Sep 30, 2025 | 133.35% |
| Jun 30, 2025 | 112.33% |
| Mar 31, 2025 | 64.51% |
| Dec 31, 2024 | 56.10% |
| Sep 30, 2024 | 61.56% |
| Jun 30, 2024 | 21.91% |
| Mar 31, 2024 | -19.77% |
| Dec 31, 2023 | 16.08% |
| Sep 30, 2023 | -20.16% |
| Jun 30, 2023 | -40.59% |
| Mar 31, 2023 | -79.04% |
| Dec 31, 2022 | 13.27% |
| Sep 30, 2022 | -390.18% |
| Jun 30, 2022 | -675.99% |
| Mar 31, 2022 | -79.05% |
| Dec 31, 2021 | -588.86% |
| Sep 30, 2021 | 632.93% |
| Jun 30, 2021 | 194.53% |
| Mar 31, 2021 | -5.47% |
| Dec 31, 2020 | -191.84% |
| Sep 30, 2020 | 130.08% |
| Jun 30, 2020 | 64.61% |
| Mar 31, 2020 | -43.16% |
| Dec 31, 2019 | -55.07% |
| Sep 30, 2019 | -257.42% |
| Jun 30, 2019 | -475.29% |
| Mar 31, 2019 | -38.84% |
| Dec 31, 2018 | -833.55% |
| Sep 30, 2018 | -169.19% |
| Jun 30, 2018 | -163.30% |
| Mar 31, 2018 | -248.01% |
| Dec 31, 2017 | 96.92% |
| Sep 30, 2017 | 26.68% |
| Jun 30, 2017 | 31.53% |
| Mar 31, 2017 | -18.21% |
| Dec 31, 2016 | -178.61% |
| Sep 30, 2016 | 526.47% |
| Jun 30, 2016 | -50.21% |
| Mar 31, 2016 | 45.75% |
| Dec 31, 2015 | 61.44% |
| Sep 30, 2015 | 104.68% |
| Jun 30, 2015 | 168.45% |
| Mar 31, 2015 | 33.62% |
| Dec 31, 2014 | -8.08% |
| Mar 31, 2014 | -117.47% |